| J9271 | Injection, pembrolizumab, 1 mg | 20,700 | $40 | $890.1K |
| J1449 | Injection, eflapegrastim-xnst, 0.1 mg | 6,340 | $30 | $158.4K |
| J0897 | Injection, denosumab, 1 mg | 8,580 | $20 | $154.4K |
| 99215 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the… | 620 | $140 | $84.5K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 750 | $100 | $75.2K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 820 | $90 | $73.5K |
| J0885 | Injection, epoetin alfa, (for non-esrd use), 1000 units | 9,800 | $10 | $58.8K |
| Q5108 | Injection, pegfilgrastim-jmdb (fulphila), biosimilar, 0.5 mg | 480 | $100 | $46.1K |
| 96417 | In this add–on procedure, the provider continues administration of a chemotherapy drug into a vein using an infusion technique. He uses this code to report administration of a different chemotherapy… | 440 | $50 | $21.9K |
| Q5106 | Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units | 3,320 | $10 | $19.9K |